캐나다 - 프랑스어 - Health Canada

sandoz canada incorporated - sunitinib - capsule - 25mg - sunitinib 25mg

캐나다 - 프랑스어 - Health Canada

sandoz canada incorporated - sunitinib - capsule - 37.5mg - sunitinib 37.5mg

캐나다 - 프랑스어 - Health Canada

sandoz canada incorporated - sunitinib - capsule - 50mg - sunitinib 50mg

캐나다 - 프랑스어 - Health Canada

auro pharma inc - sunitinib (malate de sunitinib) - capsule - 12.5mg - sunitinib (malate de sunitinib) 12.5mg

캐나다 - 프랑스어 - Health Canada

auro pharma inc - sunitinib (malate de sunitinib) - capsule - 25mg - sunitinib (malate de sunitinib) 25mg

캐나다 - 프랑스어 - Health Canada

auro pharma inc - sunitinib (malate de sunitinib) - capsule - 37.5mg - sunitinib (malate de sunitinib) 37.5mg

캐나다 - 프랑스어 - Health Canada

auro pharma inc - sunitinib (malate de sunitinib) - capsule - 50mg - sunitinib (malate de sunitinib) 50mg

유럽 연합 - 프랑스어 - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - tériparatide - osteoporosis; osteoporosis, postmenopausal - homéostasie du calcium - teriparatide sun is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.

유럽 연합 - 프랑스어 - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabète sucré, type 2 - les médicaments utilisés dans le diabète - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. triple thérapie de combinaison) en complément d'un régime alimentaire et l'exercice chez les patients insuffisamment contrôlés sur leur dose maximale tolérée de metformine et une sulphonylurea. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

스위스 - 프랑스어 - Swissmedic (Swiss Agency for Therapeutic Products)

sun store health care ag - acetylcysteinum - comprimés effervescents - acetylcysteinum 600 mg, acide citricum, natrii hydrogenocarbonas corresp. sodium 345 mg, macrogolum 6000, sont, aspartamum 15 mg, acesulfamum kalicum, e 160(a) synthétique 0,75 mg, riboflavini natrii phosphas, de la silice colloidalis anhydrica pro compresso. - mukolytikum - synthetika